Carlyle Group Inc.

Q2 2022 13F-HR Holdings

Location
Washington, DC
Holdings as of
6/30/2022
Date filed
8/12/2022
Form type
13F-HR
Num holdings
9
Total value ($000)
$5,799
Net value change ($000)
-2,561 (-30.6%)
New positions
3
Sold out positions
1
Turnover %
59.0%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 5/13/2022 Next filing: 11/10/2022 SEC filing

Snapshot: Change Analysis

Compared to Q1 2022
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
QDEL 1,211 NEW
Vitru Ltd 10 10.1%
EM 5 NEW
Top Reduces (Value $000, Stocks/ETFs)
Ortho Clinical Diagnostics Holdings plc -2,204 -100.0%
GTM -1,139 -45.1%
Atotech Ltd -399 -11.8%
1Life Healthcare Inc -44 -29.1%
SMHI -2 -22.2%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type